Elizabeth C. Smyth

Oncology

1275 York Ave
New York, NY 10065

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 226 publications

DKN-01 and atezolizumab as second- or third-line therapy in advanced oesophagogastric adenocarcinoma: the WAKING trial.

DKN-01 and atezolizumab as second- or third-line therapy in advanced oesophagogastric adenocarcinoma: the WAKING trial.

Journal: ESMO gastrointestinal oncology

Published: September 03, 2026

Zolbetuximab plus pembrolizumab and chemotherapy in CLDN18.2-positive, HER2-negative, PD-L1-positive gastric or gastroesophageal junction adenocarcinoma: randomized, double-blind, phase III LUCERNA trial.

Zolbetuximab plus pembrolizumab and chemotherapy in CLDN18.2-positive, HER2-negative, PD-L1-positive gastric or gastroesophageal junction adenocarcinoma: randomized, double-blind, phase III LUCERNA trial.

Journal: ESMO gastrointestinal oncology

Published: August 12, 2026

Promising New Platforms and Targets in the Management of Gastroesophageal Cancers.

Promising New Platforms and Targets in the Management of Gastroesophageal Cancers.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: May 07, 2026

Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons.

Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons.

Journal: Nature reviews. Clinical oncology

Published: April 24, 2026

DESTINY-Gastric05 phase III trial of first-line trastuzumab deruxtecan, chemotherapy, and pembrolizumab in HER2-positive gastric or gastroesophageal junction cancer.

DESTINY-Gastric05 phase III trial of first-line trastuzumab deruxtecan, chemotherapy, and pembrolizumab in HER2-positive gastric or gastroesophageal junction cancer.

Journal: ESMO gastrointestinal oncology

Published: April 17, 2026

Visualization of Multi-indication Randomized Control Trial Evidence to Support Decision Making in Oncology: A Case Study on Bevacizumab.

Visualization of Multi-indication Randomized Control Trial Evidence to Support Decision Making in Oncology: A Case Study on Bevacizumab.

Journal: Medical decision making : an international journal of the Society for Medical Decision Making

Published: March 31, 2026

Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation.

Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation.

Journal: ESMO open

Published: March 10, 2026

Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS study.

Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS study.

Journal: BMC cancer

Published: March 09, 2026

Research training, barriers, and career development needs of early-career investigators in oncology: an EORTC survey-based study.

Research training, barriers, and career development needs of early-career investigators in oncology: an EORTC survey-based study.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

ESMO podcast on upper gastrointestinal cancers-highlights in esophagogastric cancers from ASCO 2025.

ESMO podcast on upper gastrointestinal cancers-highlights in esophagogastric cancers from ASCO 2025.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

ISDE guidelines on the management of cT2N0 esophageal cancer.

ISDE guidelines on the management of cT2N0 esophageal cancer.

Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus

Published: January 23, 2026

Current landscape, successes, and key challenges in cancer vaccine clinical trials across the UK.

Current landscape, successes, and key challenges in cancer vaccine clinical trials across the UK.

Journal: The Lancet. Oncology

Published: December 25, 2025

Showing 1-12 of 226

Last Updated: 09/26/2026